Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma-Reference-Cited by-同舟云学术

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma

Published:2019-01-01 Issue:1 Volume:155 Page:22
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Almutairi Abdulaali R.¹²,Alkhatib Nimer S.¹²,Oh Mok¹²,Curiel-Lewandrowski Clara³⁴,Babiker Hani M.⁴⁵,Cranmer Lee D.⁶⁷,McBride Ali²⁴,Abraham Ivo¹²⁴⁸⁹

Affiliation:

1. Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, The University of Arizona, Tucson

2. Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson

3. Division of Dermatology, Department of Medicine, College of Medicine, The University of Arizona, Tucson

4. The University of Arizona Cancer Center, Tucson

5. Division of Hematology-Oncology, Department of Medicine, College of Medicine, The University of Arizona, Tucson

6. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle

7. Seattle Cancer Care Alliance, Seattle, Washington

8. Department of Family and Community Medicine, College of Medicine, The University of Arizona, Tucson

9. Matrix45, Tucson, Arizona

Publisher

American Medical Association (AMA)

Subject

Dermatology

Reference31 articles.

1. Cancer statistics, 2018.;Siegel;CA Cancer J Clin,2018

2. Projections of the cost of cancer care in the United States: 2010-2020.;Mariotto;J Natl Cancer Inst,2011

3. Regional therapies for locoregionally advanced and unresectable melanoma.;Weitman;Clin Exp Metastasis,2018

4. Metastatic melanoma: recent therapeutic progress and future perspectives.;Malissen;Drugs,2018

5. Immuno-oncology combinations: a review of clinical experience and future prospects.;Antonia;Clin Cancer Res,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Cost-Effectiveness Evidence for FDA-Approved Cell and Gene Therapies;Human Gene Therapy;2024-06-01

2. Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma;JAMA Dermatology;2023-11-01

3. Sensitivity Analysis in Economic Evaluations of Immuno-Oncology Drugs: A Systematic Literature Review;Value in Health Regional Issues;2023-09

4. Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study;British Journal of Dermatology;2023-07-24

5. Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal;Expert Review of Pharmacoeconomics & Outcomes Research;2023-04-19